Duopharma on Friday received a conditional registration approval for the vaccine and is likely to sign an agreement by month-end with more details to be announced then.
PETALING JAYA: Earnings contribution for the potential supply of Sinopharm Covid-19 vaccine to the government by Duopharma Biotech Bhd
is expected to be marginal.
The company on Friday received a conditional registration approval for the vaccine and is likely to sign an agreement by month-end with more details to be announced then.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
